- Home
- KOD vs ARL Comparison
KOD vs ARL Comparison
Compare KOD & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- ARL
- Stock Information
- Founded
- KOD 2009
- ARL 1999
- Country
- KOD United States
- ARL United States
- Employees
- KOD N/A
- ARL N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- ARL Building operators
- Sector
- KOD Health Care
- ARL Real Estate
- Exchange
- KOD Nasdaq
- ARL Nasdaq
- Market Cap
- KOD 198.4M
- ARL 205.1M
- IPO Year
- KOD 2018
- ARL N/A
- Fundamental
- Price
- KOD $10.57
- ARL $14.66
- Analyst Decision
- KOD Hold
- ARL
- Analyst Count
- KOD 4
- ARL 0
- Target Price
- KOD $11.25
- ARL N/A
- AVG Volume (30 Days)
- KOD 681.7K
- ARL 4.1K
- Earning Date
- KOD 08-13-2025
- ARL 08-07-2025
- Dividend Yield
- KOD N/A
- ARL N/A
- EPS Growth
- KOD N/A
- ARL N/A
- EPS
- KOD N/A
- ARL N/A
- Revenue
- KOD N/A
- ARL $48,139,000.00
- Revenue This Year
- KOD N/A
- ARL N/A
- Revenue Next Year
- KOD N/A
- ARL N/A
- P/E Ratio
- KOD N/A
- ARL N/A
- Revenue Growth
- KOD N/A
- ARL N/A
- 52 Week Low
- KOD $1.92
- ARL $9.43
- 52 Week High
- KOD $11.60
- ARL $19.68
- Technical
- Relative Strength Index (RSI)
- KOD 77.63
- ARL 63.53
- Support Level
- KOD $7.69
- ARL $12.64
- Resistance Level
- KOD $8.45
- ARL $14.72
- Average True Range (ATR)
- KOD 0.83
- ARL 0.73
- MACD
- KOD 0.17
- ARL 0.24
- Stochastic Oscillator
- KOD 85.66
- ARL 97.24
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About ARL American Realty Investors Inc.
American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.